In part 3 of this video interview, Kristy Birchard, product owner, patient engagement, YPrime touches on the importance of utilizing patient-reported outcomes.
ACT: How can sponsors leverage electronic clinical outcome assessment (eCOA) technologies to facilitate the collection and management of patient-reported outcomes (PROs)? How does this contribute to a more patient-centric approach?
Birchard: I am actually such a big fan of ePROs. I've been working in the clinical trial industry for eight, nine years now, because after graduate school, I was focusing on patient-centric research design, and I really wanted to find a space where that was happening, and in the clinical trial space, especially in the ePRO space, was where I saw the most influential work being done—incorporating patient and caregiver knowledge as a crucial part of science and understanding knowledge as both live knowledge and scientific knowledge. It was really exciting for me to get into this space. I always say I'm a patient first. That's why I got into this industry.
Patient-reported outcomes allow patients to report symptoms at home, they allow patients a lot more convenience and flexibility of how they report symptoms. Also, the biggest part for me is that they actually often, if done right, and in a patient centric way give patients a voice that they're not always granted in in our system. I really strongly believe that ePROs specifically have so much value in the clinical trial industry because, again, they give patients more opportunities to use these tools as a voice and a way to report how we're living with or managing our illnesses. I think that, in itself, is crucial to the conversation of patient centricity and building these tools with patients is also very important.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.